(Journal Article): The NF-kappaB pathway as a potential target for autoimmune disease therapy.
Bacher S, Schmitz ML
IN:
Curr Pharm Des
2004; 10(23):2827-2837
Impact Factor(s) of Curr Pharm Des: 5.385 (2004), 5.55 (2003), 4.692 (2002), 3.204 (2001)
ABSTRACT: A battery of proinflammatory agents triggers the activation of NF-kappaB. This inducible transcription factor participates in the expression of an exceptionally large number of tar... Click HERE for details
|
||